Related Experiment Video
Updated: Nov 8, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study
Stephanie M Ware1, James D Wilkinson2, Muhammad Tariq3
1Departments of Pediatrics and Medical and Molecular Genetics Indiana University School of Medicine Indianapolis IN.
Insights
Genetic testing identifies the cause of pediatric cardiomyopathy in many children, even those with no family history. Routine genetic testing is recommended due to significant diagnostic yield and practice variations.
Area of Science:
- Genetics
- Pediatrics
- Cardiology
Background:
- Pediatric cardiomyopathy is a serious genetic disorder with high mortality.
- Current genetic testing guidelines exist but are inconsistently applied.
- Data on clinical testing practices and diagnostic yield in children are limited.
Purpose of the Study:
- To identify genetic causes of cardiomyopathy in children.
- To investigate clinical genetic testing practices and their diagnostic yield.
- To support routine genetic testing for pediatric cardiomyopathy.
Main Methods:
- Exome sequencing was performed on 152 pediatric probands with familial or idiopathic cardiomyopathy from 14 North American institutions.
- Rare variants in 37 known cardiomyopathy genes were assessed using clinical interpretation guidelines.
- Clinical genetic testing history and family history were recorded.
Main Results:
- A molecular cause was identified in 53% of children who underwent prior clinical genetic testing.
- An additional 21% of children without prior testing received a molecular diagnosis via exome sequencing.
- Genetic testing rates varied widely (0% to 97%) across participating sites.
Conclusions:
- A definitive molecular genetic diagnosis is achievable in a significant proportion of pediatric cardiomyopathy cases.
- Significant practice variations in genetic testing necessitate standardization.
- Routine genetic testing for both familial and idiopathic pediatric cardiomyopathy is supported by these findings.
Abstract:
Background Pediatric cardiomyopathy is a genetically heterogeneous disease with substantial morbidity and mortality. Current guidelines recommend genetic testing in children with hypertrophic, dilated, or restrictive cardiomyopathy, but practice variations exist. Robust data on clinical testing practices and diagnostic yield in children are lacking. This study aimed to identify the genetic causes of cardiomyopathy in children and to investigate clinical genetic testing practices. Methods and Results Children with familial or idiopathic cardiomyopathy were enrolled from 14 institutions in North America. Probands underwent exome sequencing. Rare sequence variants in 37 known cardiomyopathy genes were assessed for pathogenicity using consensus clinical interpretation guidelines. Of the 152 enrolled probands, 41% had a family history of cardiomyopathy. Of 81 (53%) who had undergone clinical genetic testing for cardiomyopathy before enrollment, 39 (48%) had a positive result. Genetic testing rates varied from 0% to 97% between sites. A positive family history and hypertrophic cardiomyopathy subtype were associated with increased likelihood of genetic testing (P=0.005 and P=0.03, respectively). A molecular cause was identified in an additional 21% of the 63 children who did not undergo clinical testing, with positive results identified in both familial and idiopathic cases and across all phenotypic subtypes. Conclusions A definitive molecular genetic diagnosis can be made in a substantial proportion of children for whom the cause and heritable nature of their cardiomyopathy was previously unknown. Practice variations in genetic testing are great and should be reduced. Improvements can be made in comprehensive cardiac screening and predictive genetic testing in first-degree relatives. Overall, our results support use of routine genetic testing in cases of both familial and idiopathic cardiomyopathy. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT01873963.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Animal Mitochondrial Genetics
Cardiomyopathy V: Interprofessional Care

